Security key
92532F100
VERTEX PHARMACEUTICALS INC / MA - Common Stock (VRTX)
CUSIP: 92532F100
Q2 2024 13F Holders as of 30 Jun 2024
- Security type / class
- Equity / Common Stock
- Total 13F shares
- 234,132,938
- Total 13F value
- $109,741,428,164
- Share change
- +178,176
- Put/Call ratio
- 131%
- SEC-reported price per share
- $468.72
- Number of holders
- 1,538
- Value change
- +$127,466,437
- Number of buys
- 806
- Number of sells
- 605
- Shares outstanding
- 254,406,089
Holder snapshot
7 signals
Open additional details 1 more signal available
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q2 2024
Institutions
1,538
Top holders
10
VRTX full security history
Ownership snapshot
Full 13F holder table
Newer quarter: Q3 2024
Previous quarter: Q1 2024
VERTEX PHARMACEUTICALS INC / MA SEC filings
VERTEX PHARMACEUTICALS INC / MA company facts
Broader feeds
Reporting periods
Holder history for CUSIP 92532F100
Recent filing periods:
Ownership snapshot
Top reported holders of VRTX - VERTEX PHARMACEUTICALS INC / MA - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
Capital World Investors
Disclosed value leader
Capital World Investors
Comparable rows
15/15
Latest evidence
31 Mar 2024
13F
Lead comparable stake: 10%
Showing 1-6 of 15 holder rows.
Quick read
Capital World Investors leads the comparable SEC ownership view at 10%.
15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens Capital World Investors's linked filing trail.
Comparable ownership
Top 5
Capital World Investors
10%
VANGUARD GROUP INC
8.9%
BlackRock Finance, Inc.
8.6%
STATE STREET CORP
4.7%
FMR LLC
4.2%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| Capital World Investors |
13F
Company
|
10%
|
$10,687,338,555
25,567,184 shares
|
— | 31 Mar 2024 |
| VANGUARD GROUP INC |
13F
Company
|
8.9%
|
$9,479,011,289
22,676,518 shares
|
— | 31 Mar 2024 |
| BlackRock Finance, Inc. |
13F
Company
|
8.6%
|
$9,179,786,674
21,960,687 shares
|
— | 31 Mar 2024 |
| STATE STREET CORP |
13F
Company
|
4.7%
|
$5,018,829,959
12,006,483 shares
|
— | 31 Mar 2024 |
| FMR LLC |
13F
Company
|
4.2%
|
$4,461,637,923
10,673,520 shares
|
— | 31 Mar 2024 |
| ALLIANCEBERNSTEIN L.P. |
13F
Company
|
2.8%
|
$2,966,734,431
7,097,281 shares
|
— | 31 Mar 2024 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q2 2024
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
1,538
Shares
234,132,938
Rows available
1,538
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q2 2024 vs Q1 2024 Across Filers
Q1 2024 holders
1,481
Q2 2024 holders
1,538
Holder diff
57
| Investor | Q1 2024 Shares | Q2 2024 Shares | Share Diff | Share Chg % | Q1 2024 value | Q2 2024 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend